Perry Nisen Archives - Sanford Burnham Prebys
Institute News

SBP President’s Circle members gather at CEO’s home

AuthorHelen I. Hwang
Date

June 19, 2017

On a lovely June evening, SBP CEO Perry Nisen, MD, PhD, and his wife Amy opened up their La Jolla home to President’s Circle members. It was an intimate, warm gathering as SBP supporters, board members, friends and scientists mingled together with a backyard view overlooking the glistening Pacific Ocean.

Dr. Nisen thanked the President’s Circle supporters and emphasized the importance of their contributions. He explained that the investment made by donors boosts the “opportunity to translate scientific research into medicines. And it’s really happening here. It’s also happening in a time of tremendous funding challenges.” Dr. Nisen further shared how his own father died of Parkinson’s disease and shared how heartbreaking it was to watch the deterioration of a loved one.

To elaborate further on the current state of neurodegenerative research, Dr. Jerold Chun, professor in the Neuroscience and Aging Research Center and senior vice-president, Neuroscience Drug Discovery, discussed the dire need for more research for the estimated 5 million Americans that suffer from Alzheimer’s disease and the 1 million diagnosed with Parkinson’s disease. The numbers of patients will only increase as our population ages. Dr. Chun pointed out that out of all the research institutions on the Torrey Pines Mesa, we have a leader with the unique background of translating biomedical research into drugs for patients that need better therapeutic options.

After the brief talks, guests munched over caramel-braised pork belly, char miso barramundi, mini French macaroons, and flatbread from an outdoor, custom-built brick wood-fired pizza oven fired up for the first time for this special occasion for SBP friends.

As President’s Circle members, they receive invitations to exclusive events and have the opportunity to meet SBP scientists and leadership as well as receiving Institute news via monthly Discoveries newsletters and Pathways magazine.

To join the President’s Circle, click here.

 

 

 

Institute News

SBP and GSK create new Center for Translational Neuroscience

Authorkcusato
Date

April 20, 2016

SBP and GlaxoSmithKline (GSK), a global pharmaceutical company, have announced the creation of the SBP-GSK Center for Translational Neuroscience. The new Center, located on the SBP campus in La Jolla, will bring together experts from SBP and GSK to investigate factors that influence brain function and potentially reverse or slow down neurodegeneration, with the aim of identifying and validating new therapeutic targets. Under the three year agreement, GSK will provide funding to create and support a research laboratory. Staffed by SBP scientists, postdoctoral candidates and technicians working alongside neuroscientists from GSK, the Center will be designed to bolster research dedicated to translational neuroscience. Continue reading “SBP and GSK create new Center for Translational Neuroscience”

Institute News

A $100 million gift and a new name

Authorpbartosch
Date

June 24, 2015

We are beyond excited to announce that Sanford-Burnham has received a gift of $100 million from prominent San Diego developer, philanthropist, and Sanford-Burnham honorary trustee Conrad Prebys. This is the largest donation ever made by Prebys and will be used to further implement the Institute’s 10-year strategic vision to accelerate the delivery of innovative new treatments that will have a tangible impact on improving human health. Continue reading “A $100 million gift and a new name”

Institute News

2015 Sanford-Burnham faculty retreat

Authorsgammon
Date

June 5, 2015

The annual Sanford-Burnham faculty retreat was held in beautiful Carlsbad, Calif., May 19-20. Attended by more than 70 faculty from La Jolla, Calif., and Lake Nona, Fla., the retreat was an opportunity for attendees to learn more about each other’s research, share ideas, and to engage in strategic discussions related to the Institute’s 10-year vision to become a preeminent medical research institute that combines cutting-edge fundamental research with robust drug discovery. Continue reading “2015 Sanford-Burnham faculty retreat”

Institute News

Lilly and Sanford-Burnham announce collaboration to investigate immunological therapies

Authorpbartosch
Date

May 14, 2015

Today, Eli Lilly and Sanford-Burnham announced a novel collaboration to discover and develop immunological therapies. The two organizations will investigate potential therapeutics using biotechnology approaches in targeting multiple immune checkpoint modulators for the treatment of immunological diseases such as lupus, Sjögren’s syndrome, inflammatory bowel disease, and other autoimmune disorders. Continue reading “Lilly and Sanford-Burnham announce collaboration to investigate immunological therapies”

Institute News

Sanford-Burnham small molecule licensed to Daiichi Sankyo

Authorpbartosch
Date

April 21, 2015

 

We’re excited to announce that Sanford-Burnham has signed a licensing agreement with Daiichi Sankyo to further develop a first-in-class small molecule for the treatment of cardiovascular-metabolic disease. The small molecule is based on longstanding, groundbreaking biology work by one of our scientists and his laboratory team, who for decades focused their research on treating a consequence of cardiovascular-metabolic disease. Continue reading “Sanford-Burnham small molecule licensed to Daiichi Sankyo”

Institute News

Happy Holidays from Sanford-Burnham!

Authorpbartosch
Date

December 23, 2014

As the year draws to a close, we look back on Sanford-Burnham’s many achievements in 2014. Over the year, our scientists published numerous papers in high-profile journals; secured significant grant funding; partnered with companies, institutes, and nonprofit organizations from across the country and the globe; and they took important steps toward our ultimate goal – to have a tangible impact on human health. Here are 14 accomplishments of 2014 that we are proud to share with you: Continue reading “Happy Holidays from Sanford-Burnham!”

Institute News

Karen and Stuart Tanz give $1 million to Sanford-Burnham and the University of Toronto

Authorrbruni
Date

November 3, 2014

 

A $1-million gift will establish an international collaboration between Sanford-Burnham and the Tanz Centre for Research in Neurodegenerative Diseases at the University of Toronto to accelerate the development of new therapeutics to treat neurodegenerative diseases. Continue reading “Karen and Stuart Tanz give $1 million to Sanford-Burnham and the University of Toronto”

Institute News

Sanford-Burnham announces next CEO

Authoradmin
Date

August 19, 2014

We are thrilled to announce that Sanford-Burnham’s Board of Trustees has appointed Perry Nisen, MD, PhD, as the Institute’s chief executive officer and holder of the Donald Bren Chief Executive Chair. In this role, he will lead the Institute and oversee the execution of our new 10-year strategic vision to more quickly translate basic research discoveries into novel treatments that improve human health. Dr. Nisen joins us from GlaxoSmithKline (GSK) – a British multinational pharmaceutical company – where he was senior vice president of Science and Innovation. Continue reading “Sanford-Burnham announces next CEO”